Professional Documents
Culture Documents
Definition
Anemia is the condition in which the
concentration of hemoglobin or the
red cell mass is reduced below (-2SD)
Hemoglobin (g/dl)
AGE
Mean
-2SD
MCV (FL)
Mean
-2SD
13,5
108
98
14,5
107
105
104
96
9,5
10,5
11,5
11,5
108
88
86
85
77
91
78
81
86
95
74
70
75
77
Compiled from several sources; the mean 2 SD can be expected to include 95% of the
observations in normal population. In Rudolph AM, Kamei RK (eds), Rudolphs Fundamentals of
3
pediatrics, 2 nd ed. Norwalk, CT: Appleton & lange, 1998, p 441-490
MCV = mean corpuscular volume
Characteristics
Etiology related to abnormalities
associated with iron metabolism
Maturation disorder
Reticulocyte production index (RPI) <2.0
Predominantly microcytic RBCs
Variable red blood cell distribution width
(RDW)
5
Etiologic classification
Impaired red cell formation
Deficiency
Bone marrow failure
Failure of a single cell line
Failure of all cell lines
Infiltration
Dyshematopoietic anemia
Infection
Renal failure and hepatic disease
Disseminate malignancy
Connective tissue diseases
Blood loss
Hemolytic anemia
Corpucular
Extra corpuscular
Iron sufficient
Children
Hb(gr/l)
Ferritin (g/l)
Transferrin
saturation (%)
EPP (mol/mol heme)
Iron
depletion
non anemic
I ron
deficient
erythropoesis
Iron
deficient
anemia
110
12
110
< 12
110
< 12
<110
< 12
10
10
<10
<10
< 100
< 100
100
100
10
11
12
Hemogram Patterns
Moderate cases
Hgb
Hct
MCV
MCH
Normocytic/
normochromic
Severe cases
Hgb
Hct
MCV
MCH
Microcytic/hypochromic
Poikilocytosis
13
14
Moderate
Severe
15
17
Secondary Laboratory
Investigation
Serum ferritin
Serum iron
Iron binding capacity
Prussian Blue (iron) stain
18
Serum Ferritin
20-250 ug/L
10-120 ug/L
See below
19
Serum Ferritin
Pediatric reference range:
1 month:
200-600 ug/L
1-6 months: Comparable to adult males
Childhood:
Generally low ferritin levels
Considerations
Elevated during acute inflammatory
processes
No diurnal variation
20
Serum Ferritin
Considerations, continued
Not changed by exogenous iron
ingestion
21
Serum Iron
Measurement of transferrin-bound iron
Serum iron:
Male:
Female:
60-175 ug/dL
50-170 ug/dL
Considerations
Hemolysis may significantly affect test results
Chelating anticoagulants may lead to falsely
decreased results
22
Serum Iron
Considerations:
Diurnal variation: AM Peak, PM Trough
Fasting specimen
Iron-containing medication can lead to falsely
Iron
increased results
12 AM
12 PM
12 AM
23
Total Iron
Binding Capacity
Measures the potential binding capacity of
circulating transferrin
With serum Fe used to determine
saturation
Total iron binding capacity: Reference
range 250-450 ug/dL
24
25
Transferrin Saturation
Transferrin
%
Saturation
Serum iron
TIBC
X 100
26
28
29
30
31
Sideroblasts
Type II
>6 granules/cell
Random cytoplasmic distribution
Type III
Larger granules
Arranged in ring around the nucleus
>15% indicate sideroblastic anemia
32
Effects of Treatment
Treatment consists of:
Iron supplementation and/or
Controlling underlying disease
Laboratory effects
Increased reticulocyte count within days
(RPI>3)
Peak reticulocyte count in 7-12 days
Hemoglobin returns to normal in
approximately 2 months
33
Treatment
Laboratory effects, Continued
Peripheral RBC dimorphism appears as
hemoglobin level returns to normal
Changes in RBC histogram
Return of measures of iron store status to
normal levels
Ineffective treatment/complications
34
Oral Iron
Standard oral treatment of iron deficiency is 3 mg iron/kg
body weight/day , max 180 mg daily
Three milligrams of iron is provided by :
15 mg ferrous sulfate
9 mg ferrous fumarate
26 mg ferrous gluconate
9 mg ferrous succinate
17 mg ferrous glycine sulfate
21 mg sodium iron edetate
9 mg ferrous sulfate dried
35
Preparation
Preparation (ml)
Amount of iron
in preparation (mg)
Amount of preparation
to provide 3 mg (ml)
Ferrous sulfate
oral solution
Ferrous fumarate BP
12
1,25
45
0,3
Ferrous succinate
elixir
Ferrous glycine
sulfate
Sodium iron
edetate
Polysaccharide iron
complex
37
0,4
25
0,6
28
0,5
100
0,15
36
Iron / 100 g
0,9
2,0
2,3
0,9
1,0
1,5
7,1
% available for
1
5
5
10
10
10
10
37
Decreased absorption
Alkalis
Antacids
Pancreatic secretions
Precipitating agents (vegetables)
Phytates
Phosphates
38
39
Other Disorders
Anemia of chronic disease
Hemochromatosis/iron overload
40
Summary
Characteristics of anemias of abnormal
iron metabolism
Hemogram patterns
Natural course of IDA
Secondary laboratory investigation
Sideroblasts
Effects of treatment
Other Disorders
41
42
43
44